1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Wang, Y.
Henz, M.E.
Gallagher, N.L.F.
Chai, S.
Yan, L.Z.
Gibbs, A.C.
Stiles, M.E.
Wishart, D.S.
Vederas, J.C.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
38
15438
15447
10.1021/bi991351x
10569926
Solution structure of carnobacteriocin B2 and implications for structure-activity relationships among type IIa bacteriocins from lactic acid bacteria.
1999
10.2210/pdb1cw5/pdb
pdb_00001cw5
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
4974.490
TYPE IIA BACTERIOCIN CARNOBACTERIOCIN B2
1
nat
polymer
no
no
VNYGNGVSCSKTKCSVNWGQAFQERYTAGINSFVSGVASGAGSIGRRP
VNYGNGVSCSKTKCSVNWGQAFQERYTAGINSFVSGVASGAGSIGRRP
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Carnobacterium
sample
2751
Carnobacterium maltaromaticum
database_2
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
1
0
1999-09-07
1
1
2008-04-27
1
2
2011-07-13
1
3
2022-02-16
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
RCSB
Y
RCSB
1999-08-25
REL
REL
THIS STRUCTURE WAS DETERMINED USING STANDARD 2D HOMONUCLEAR TECHNIQUES. THE
STRUCTURE WAS DETERMINED USING TRIPLE-RESONANCE NMR SPECTROSCOPY.
STRUCTURES WITH ACCEPTABLE COVALENT GEOMETRY,STRUCTURES WITH FAVORABLE NON-
BOND ENERGY,STRUCTURES WITH THE LEAST RESTRAINT VIOLATIONS,STRUCTURES WITH THE
LOWEST ENERGY
30
20
2D NOESY
0
2.8
AMBIENT
298
K
THE STRUCTURES ARE BASED ON A TOTAL OF 319 PROTON DISTANCE RESTRAINTS, 88
DIHEDRAL ANGLE RESTRAINTS, 8 3JHNHA COUPLING CONSTANT RESTRAINTS, AND 163
PROTON CHEMICAL SHIFT RESTRAINTS.
simulated annealing
6
closest to the average
5.0 MG CARNOBACTERIOCIN B2 IS DISOLVED IN 700 UL OF TFE-D3/H2O, 90%:10% V/V,
PH 2.8.
BRUNGER
structure solution
X-PLOR
3.85
VARIAN
processing
VNMR
5.1
BRUNGER
refinement
X-PLOR
3.85
600
Varian
UNITY
500
Varian
UNITY
VAL
1
n
1
VAL
1
A
ASN
2
n
2
ASN
2
A
TYR
3
n
3
TYR
3
A
GLY
4
n
4
GLY
4
A
ASN
5
n
5
ASN
5
A
GLY
6
n
6
GLY
6
A
VAL
7
n
7
VAL
7
A
SER
8
n
8
SER
8
A
CYS
9
n
9
CYS
9
A
SER
10
n
10
SER
10
A
LYS
11
n
11
LYS
11
A
THR
12
n
12
THR
12
A
LYS
13
n
13
LYS
13
A
CYS
14
n
14
CYS
14
A
SER
15
n
15
SER
15
A
VAL
16
n
16
VAL
16
A
ASN
17
n
17
ASN
17
A
TRP
18
n
18
TRP
18
A
GLY
19
n
19
GLY
19
A
GLN
20
n
20
GLN
20
A
ALA
21
n
21
ALA
21
A
PHE
22
n
22
PHE
22
A
GLN
23
n
23
GLN
23
A
GLU
24
n
24
GLU
24
A
ARG
25
n
25
ARG
25
A
TYR
26
n
26
TYR
26
A
THR
27
n
27
THR
27
A
ALA
28
n
28
ALA
28
A
GLY
29
n
29
GLY
29
A
ILE
30
n
30
ILE
30
A
ASN
31
n
31
ASN
31
A
SER
32
n
32
SER
32
A
PHE
33
n
33
PHE
33
A
VAL
34
n
34
VAL
34
A
SER
35
n
35
SER
35
A
GLY
36
n
36
GLY
36
A
VAL
37
n
37
VAL
37
A
ALA
38
n
38
ALA
38
A
SER
39
n
39
SER
39
A
GLY
40
n
40
GLY
40
A
ALA
41
n
41
ALA
41
A
GLY
42
n
42
GLY
42
A
SER
43
n
43
SER
43
A
ILE
44
n
44
ILE
44
A
GLY
45
n
45
GLY
45
A
ARG
46
n
46
ARG
46
A
ARG
47
n
47
ARG
47
A
PRO
48
n
48
PRO
48
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
A
HG22
H
VAL
ASN
1
2
0.64
1
A
A
CG2
H
VAL
ASN
1
2
1.34
1
A
A
O
H
THR
ASN
27
31
1.58
4
A
A
HG21
H
VAL
ASN
1
2
0.55
4
A
A
HG23
CD2
VAL
TYR
1
3
0.96
4
A
A
HG23
CE2
VAL
TYR
1
3
1.01
4
A
A
HG13
HG13
VAL
VAL
1
7
1.27
4
A
A
HG12
HD2
VAL
TYR
1
3
1.32
4
A
A
HG21
N
VAL
ASN
1
2
1.51
4
A
A
CG2
H
VAL
ASN
1
2
1.57
4
A
A
CG2
CE2
VAL
TYR
1
3
1.67
4
A
A
CG2
CD2
VAL
TYR
1
3
2.00
4
A
A
CG1
CG1
VAL
VAL
1
7
2.16
5
A
A
O
HG1
GLN
THR
23
27
1.47
6
A
A
O
H
THR
ASN
27
31
1.54
13
A
A
HG12
H
VAL
ASN
1
2
1.02
13
A
A
O
HG
ALA
SER
28
32
1.53
14
A
A
HG21
H
VAL
ASN
1
2
1.32
15
A
A
O
HG1
GLN
THR
23
27
1.59
16
A
A
HG13
H
VAL
ASN
1
2
1.28
16
A
A
O
HD2
PHE
TYR
22
26
1.51
16
A
A
O
HG
ALA
SER
28
32
1.58
17
A
A
HG23
H
VAL
ASN
1
2
0.78
17
A
A
HG22
CE2
VAL
TYR
1
3
0.99
17
A
A
HG22
CD2
VAL
TYR
1
3
1.13
17
A
A
HG22
HE2
VAL
TYR
1
3
1.33
17
A
A
CG2
CE2
VAL
TYR
1
3
1.82
17
A
A
CG2
CD2
VAL
TYR
1
3
2.10
18
A
A
O
HG1
GLN
THR
23
27
1.41
19
A
A
HG11
HB2
VAL
ASN
1
5
0.50
19
A
A
HG21
H
VAL
ASN
1
2
0.74
19
A
A
HG23
H
VAL
ASN
1
5
1.29
19
A
A
HG23
N
VAL
ASN
1
5
1.31
19
A
A
CG1
HB2
VAL
ASN
1
5
1.37
19
A
A
O
HG1
GLN
THR
23
27
1.40
19
A
A
HG21
N
VAL
ASN
1
2
1.53
19
A
A
HG11
CB
VAL
ASN
1
5
1.55
20
A
A
HG13
H
VAL
ASN
1
2
0.99
20
A
A
HG13
N
VAL
ASN
1
2
1.52
20
A
A
O
HD2
PHE
TYR
22
26
1.54
1
A
ASN
5
-162.63
29.64
1
A
LYS
11
45.21
163.45
1
A
THR
12
-90.05
58.82
1
A
LYS
13
-158.25
-90.38
1
A
CYS
14
75.27
93.71
1
A
SER
15
-162.20
-47.87
1
A
VAL
16
-164.69
117.09
1
A
ALA
41
179.04
82.70
1
A
ILE
44
-178.21
69.24
1
A
ARG
46
-100.42
54.97
2
A
TYR
3
68.90
86.63
2
A
ASN
5
-162.74
-64.82
2
A
VAL
7
62.98
-64.82
2
A
SER
8
48.48
92.10
2
A
CYS
9
54.55
89.05
2
A
THR
12
-88.95
-84.16
2
A
LYS
13
-158.37
38.63
2
A
VAL
16
-163.65
99.90
2
A
ALA
21
-56.94
-70.04
2
A
ALA
41
65.91
74.89
2
A
ARG
46
66.13
118.76
3
A
ASN
2
-161.10
-45.12
3
A
SER
10
-163.59
92.28
3
A
LYS
13
68.60
-69.38
3
A
SER
15
62.96
176.39
3
A
VAL
16
-163.88
111.13
3
A
TRP
18
49.13
27.32
3
A
ALA
41
178.95
83.63
3
A
SER
43
-67.22
-75.07
4
A
ASN
2
-160.44
28.09
4
A
ASN
5
-162.33
39.34
4
A
CYS
9
-176.74
131.37
4
A
LYS
11
48.08
20.42
4
A
LYS
13
80.25
-6.65
4
A
CYS
14
69.10
-70.35
4
A
SER
15
-57.34
-167.51
4
A
VAL
16
81.15
-70.61
4
A
ASN
17
173.36
-33.31
4
A
TRP
18
-39.18
-33.99
4
A
ALA
41
83.37
-9.55
4
A
SER
43
-104.03
-65.31
4
A
ILE
44
-155.62
33.56
4
A
ARG
46
-173.55
39.36
4
A
ARG
47
42.24
85.67
5
A
ASN
2
71.11
-69.04
5
A
ASN
5
-162.47
-42.42
5
A
SER
8
60.81
95.34
5
A
LYS
13
-158.50
-68.64
5
A
CYS
14
74.31
66.25
5
A
ASN
17
63.36
-63.36
5
A
SER
43
-173.06
77.05
5
A
ILE
44
-154.58
59.87
5
A
ARG
46
58.76
-173.00
5
A
ARG
47
44.90
101.17
6
A
ASN
2
-160.78
69.50
6
A
ASN
5
79.61
71.60
6
A
SER
8
-178.87
68.67
6
A
LYS
11
77.63
129.24
6
A
THR
12
60.00
176.83
6
A
VAL
16
81.01
90.53
6
A
ILE
44
72.64
79.87
6
A
ARG
46
-160.34
98.75
7
A
TYR
3
-157.30
38.41
7
A
ASN
5
-161.55
-49.19
7
A
SER
10
-93.17
-68.84
7
A
THR
12
64.60
-65.11
7
A
CYS
14
-166.56
42.41
7
A
SER
43
62.83
66.43
7
A
ILE
44
-106.12
43.62
7
A
ARG
47
-140.01
55.02
8
A
SER
8
64.40
101.02
8
A
SER
15
-75.26
-149.53
8
A
VAL
16
-164.24
108.98
8
A
ILE
44
-166.83
60.27
8
A
ARG
46
-179.81
99.34
9
A
LYS
11
81.53
-1.72
9
A
SER
15
61.50
-177.56
9
A
VAL
16
-162.32
113.61
9
A
ALA
41
-145.35
-59.35
9
A
ILE
44
-152.18
63.77
10
A
CYS
9
-166.59
82.59
10
A
SER
10
-72.14
-163.62
10
A
CYS
14
167.28
-46.43
10
A
VAL
16
-164.50
86.98
10
A
ALA
21
-60.29
-71.55
10
A
ALA
41
-178.88
-71.42
10
A
SER
43
64.83
71.19
10
A
ARG
46
62.22
95.89
11
A
ASN
5
-161.23
53.69
11
A
VAL
7
-150.33
37.40
11
A
SER
8
-176.93
40.43
11
A
SER
10
-74.67
-73.36
11
A
ALA
41
-157.29
-72.08
12
A
ASN
2
-160.87
26.65
12
A
ASN
5
-162.59
58.30
12
A
VAL
7
51.12
88.30
12
A
SER
10
-172.73
-39.20
12
A
SER
15
-173.61
-174.22
12
A
VAL
16
-164.99
-43.29
12
A
ASN
17
-64.36
91.93
12
A
SER
43
-177.36
74.19
12
A
ARG
47
54.89
94.26
13
A
ASN
2
78.44
-58.30
13
A
TYR
3
69.65
-75.00
13
A
ASN
5
-162.76
32.97
13
A
SER
8
-143.65
-146.88
13
A
THR
12
-150.78
69.02
13
A
LYS
13
74.61
170.15
13
A
ASN
17
-63.83
-162.77
13
A
SER
43
178.26
62.86
13
A
ARG
46
61.60
69.05
14
A
ASN
2
76.16
-60.06
14
A
TYR
3
64.59
109.34
14
A
ASN
5
-163.26
-54.79
14
A
SER
8
51.30
109.68
14
A
LYS
13
-159.13
39.41
14
A
VAL
16
-164.27
33.73
14
A
ASN
17
67.37
-71.74
14
A
ILE
44
-168.52
-40.79
14
A
ARG
46
-121.07
-69.17
15
A
ASN
5
-162.67
-67.97
15
A
SER
8
61.31
126.76
15
A
CYS
9
-147.52
-88.19
15
A
SER
10
37.24
67.20
15
A
LYS
11
-162.06
-21.11
15
A
THR
12
-150.86
-21.07
15
A
CYS
14
74.22
137.06
15
A
ALA
21
-59.02
-70.02
15
A
SER
43
-171.29
-51.52
15
A
ILE
44
-150.56
-79.99
16
A
ASN
2
-162.13
-160.13
16
A
TYR
3
61.25
163.66
16
A
ASN
5
73.38
60.51
16
A
SER
8
-81.22
-148.93
16
A
LYS
11
-161.45
-77.74
16
A
CYS
14
-161.41
-74.50
16
A
VAL
16
77.45
131.82
16
A
ARG
47
56.07
89.63
17
A
ASN
2
-160.87
21.42
17
A
TYR
3
-80.69
-153.28
17
A
ASN
5
80.83
86.05
17
A
VAL
7
60.58
118.30
17
A
CYS
9
66.92
-54.92
17
A
LYS
11
78.26
-59.67
17
A
LYS
13
-159.17
-55.09
17
A
VAL
16
-163.59
100.42
17
A
ALA
21
-63.33
-71.48
17
A
ARG
47
35.36
105.13
18
A
ASN
2
-161.36
91.80
18
A
SER
10
54.23
-84.24
18
A
LYS
11
-161.66
-24.11
18
A
LYS
13
47.51
-173.78
18
A
CYS
14
-133.97
-158.48
19
A
ASN
2
-163.10
-46.43
19
A
ASN
5
74.89
63.19
19
A
VAL
7
-149.68
-42.76
19
A
SER
8
178.20
130.51
19
A
THR
12
58.36
16.41
19
A
LYS
13
-160.13
-39.35
19
A
SER
15
-173.68
137.91
19
A
VAL
16
-164.80
116.95
19
A
ALA
41
-141.80
-77.37
19
A
SER
43
-155.47
38.75
20
A
ASN
2
-161.76
-5.01
20
A
ASN
5
-162.28
63.05
20
A
CYS
9
-171.77
101.03
20
A
SER
10
-78.52
-102.23
20
A
LYS
11
-162.70
37.71
20
A
THR
12
-151.09
-77.66
20
A
CYS
14
57.89
170.71
20
A
TRP
18
-89.17
36.49
20
A
ILE
44
-133.78
-69.38
20
A
ARG
46
68.83
-65.01
20
A
ARG
47
57.36
73.22
SOLUTION STRUCTURE OF CARNOBACTERIOCIN B2
1
N
N
A
ASN
17
A
ASN
17
HELX_P
A
GLY
42
A
GLY
42
1
1
26
disulf
2.031
A
CYS
9
A
SG
CYS
9
1_555
A
CYS
14
A
SG
CYS
14
1_555
TOXIN
ANTIMICROBIAL PEPTIDE, HELIX, BACTERIOCIN, TOXIN
CBB2_CARPI
UNP
1
P38580
19
66
1CW5
1
48
P38580
A
1
1
48
1
P 1